Navigation Links
Medco Tops Fortune's Lists of 'World's Most Admired' Companies
Date:3/6/2009

Medco listed No. 1 in Health Care: Pharmacy and Other Services category; No. 5 for innovation and No. 10 for people management worldwide

FRANKLIN LAKES, N.J., March 6 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS), captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on Fortune's World's Most Admired Companies List. In addition, of all companies surveyed globally, Medco was ranked No. 5 in Innovation and No. 10 in People Management.

"To be ranked highest among our industry peers is a great honor that underscores the pioneering spirit of our people in forging a future in healthcare that improves clinical and financial outcomes for our clients and their members," said Medco Chairman and CEO David B. Snow, Jr.

Fortune, in partnership with the Hay Group, surveyed more than 650 companies across 64 industry sectors worldwide. To establish the rankings, company executives, board directors and outside analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results are featured in the March 16th issue of Fortune magazine.

According to the Fortune survey, Medco received several industry and global honors:

  • No. 1 World's Most-Admired: "Health Care: Pharmacy and Other Services" category -- with the industry's highest rank in seven attributes: innovation, people management, use of corporate assets, quality of management, financial soundness, quality of products/services and global competitiveness.
  • No. 2 in the world in the "Health Care: Pharmacy and Other Services" category for social responsibility and long-term investment.
  • No. 5 globally in Innovation.
  • No. 10 globally for People Management.
  • Among the most admired companies in New Jersey.

"Medco's more than 20,000 employees are honored to earn a place on Fortune's list of the world's most innovative companies. We are, however, even more gratified by the trust and confidence of our clients and their members as we continue to innovate around pharmacy practices that enable a new era of precision medicine -- serving as a catalyst for healthcare reform in America," continued Snow.

Medco is redefining the practice of pharmacy by training more than 1,000 of its specialist pharmacists to help improve the quality of care for patients with chronic and complex conditions -- patients who account for 96 percent of drug spending and 75 percent of overall medical spending. These pharmacists are better positioned to identify safety issues and consult more effectively with doctors to improve clinical and financial outcomes. The specialist pharmacists work within Medco Therapeutic Resource Centers(R) located nationwide and focused on major conditions that include diabetes, oncology, arthritis, high blood pressure, high cholesterol and neurology/psychology.

Medco is focused on closing gaps in clinical care, improving patient health and lowering overall medical costs. This is accomplished by partnering with member advocacy programs to engage and educate consumers, pharmacogenomics research that helps physicians in the selection of the right medicine and dose based on a patient's unique genetic make-up as well as other clinical initiatives.

About Medco

Medco Health Solutions, Inc. is a leading health care company, serving the needs of more than 60 million people. Medco, the world's most advanced pharmacy(R), provides clinically driven pharmacy services designed to improve the quality of care and lower total health care costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. Through its unique Medco Therapeutic Resource Centers(R) and the Accredo Health Group, Medco's Specialty Pharmacy, the company is creating innovative models for the care of patients with chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy -- a key element in reforming America's health care system. Medco is ranked number 51 on the Fortune 500 list, with 2008 revenues of more than $51 billion. For more information about Medco, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medco CEO to Present at the Barclays Capital Global Healthcare Conference
2. Cascade of Studies, New Clinical Tests Build the Case for Genetic Testing in Pharmacy Care Says Medco Expert
3. Medco Delivers Fourth-Quarter GAAP Diluted EPS Growth of 42 Percent; 2008 Full-Year GAAP Diluted EPS Growth of 31 Percent
4. Polymedco Introduces New Colorectal Cancer Educational Website
5. Medco Announces Date for Fourth-Quarter and Full-Year 2008 Financial Results
6. Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
7. MedCom USA, Inc. Announces Appointment of One New Board Member and Removal of Two Existing Board Members
8. Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference
9. Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference
10. MedCommons HealthURL, a New Unified Clinical Viewer Appliance, Is Integrated with EMC Open Systems Archive Solution for Healthcare Organizations
11. drugstore.com Announces Strategic Alliance With Medco Health Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , ... June 28, 2017 , ... ... announce that its 50ml Liquid Stevia Sweet Drops™ have received the Non-GMO Project ... verification process from the Non-GMO Project, the only third-party verification for non-GMO foods ...
(Date:6/28/2017)... ... 28, 2017 , ... Anyone with a remote control has seen the never-ending twists on the ... flipper will get rich in no time. But what about the buyers of the ... the buyer of a flipped house. An email recently sent to Gary Case said, ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of ... winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at ... supplier of garden pea seed. As demand grew, the small company located in Moscow, ...
(Date:6/28/2017)... Cincinnati, OH (PRWEB) , ... June 28, 2017 ... ... residents of Hamilton County and the surrounding regions access to insurance assistance and ... conjunction with Matthew 25: Ministries to assist families in the region facing financial ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly ... to survey data released today by the American Society for Dermatologic Surgery ... indicates the percentage of consumers considering a cosmetic medical procedure has doubled since ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... International plc (NASDAQ: ENDP ) announced today that ... Company in a fireside chat at Goldman Sachs, 38 th ... at 10:40 a.m. PT / 1:40 p.m. ET. The conference ... Palos Verdes, CA. A live webcast ... the Company,s website at http://www.endo.com/investors/overview . Participants should allow ...
(Date:5/24/2017)... , May 24, 2017  ivWatch LLC ... Equipment Manufacturer (OEM) Board to enable seamless integration ... patient monitoring systems, infusion pumps and other devices. ... will be able to help health care customers ... reduced risks related to IV therapy. ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: